Venture-Backed Startups

Biogaran is a French pharmaceutical brand focused on generic medicines and health products, offering health-related content and patient support initiatives. It serves patients and caregivers in France with wellness information and community programs.

1 investor

Biogazelle provides genomic and transcriptomic laboratory services from ISO17025-accredited and GCLP-compliant labs, supporting research, diagnostics, therapeutics, and clinical trials. It serves scientists and clinicians working in personalized medicine.

1 investor

Biogea develops agrotechnology products based on beneficial fungi and bacteria to increase crop yields for agricultural producers in a sustainable way. The company serves farmers with biological inputs marketed under brands including BIOGROW3 and Nitro Aire.

1 investor

Biogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.

3 investors

BIOGENA develops premium micronutrient supplements, functional drinks, and longevity services for consumer health and wellness across different life stages. The company manufactures products in Austria focused on scientific efficacy, purity, and quality standards.

1 investor

0 investors

Biogenera develops DNA-based anti-gene oligonucleotide drugs using PNA (Ag-PNA) to silence altered genes that cause serious diseases, including aggressive pediatric tumors such as neuroblastoma via its BGA002 candidate targeting the MYCN gene. The pharmaceutical biotech company operates its patented MyGenera platform to identify precision-medicine gene therapies for cancers and rare diseases.

1 investor

BioGeneration Ventures is a venture capital investor focused on early-stage biotech and life sciences companies. It works with a network of universities, startups, and large pharmaceutical companies to build and accelerate product development.

3 investors

0 investors

0 investors

BioGlitz develops biodegradable, sustainable glitter as an alternative to conventional plastic glitter, marketed for self-expression and use in fashion and beauty. The company positions its products around environmental awareness and responsible use.

1 investor

Biograil is a pre-clinical stage pharmaceutical company developing technology to convert injectable pharmaceutical products into oral capsules. It operates in the drug delivery and pharmaceutical development sector.

1 investor

Biograph runs membership-based preventive health clinics that combine whole-body MRI, blood biomarkers, cardiac and brain imaging, DEXA scans and other diagnostics in a single-day assessment to detect early risk of heart disease, cancer, metabolic dysfunction and neurodegenerative disease. Physicians review the results with members and provide personalized recommendations and follow-up care, with clinics in San Mateo and New York City.

2 investors

Biographica (Graphica) uses multi-modal machine learning and high-throughput sequencing to identify and prioritize genetic targets for crop gene-editing, working with trait developers to design effective edits. It serves agricultural biotech companies developing more productive, nutritious, and climate-resilient crops.

4 investors

1 investor

0 investors

BioGrip develops non-invasive neuromuscular sensing technology combined with adaptive AI to decode human intention and enable intuitive control of prosthetics, rehabilitation systems, and robotics. The company targets individuals with mobility impairments and muscular or peripheral nerve damage.

2 investors

Biogroup is a network of medical biology laboratories that provides diagnostic testing and lab services to patients. It emphasizes proximity and quality of care across its locations in France.

1 investor

A community biotechnology laboratory in Ecuador that democratizes access to life sciences education and research. It provides training, workspace, and support for students and entrepreneurs interested in biotechnology and experimental sciences.

1 investor

Biohaven is a biopharmaceutical company developing treatments in immunology, obesity, neuroscience, and oncology, with approved migraine therapies and a pipeline of early-to-late-stage drug development programs.

3 investors

0 investors

Biohaven is a publicly traded biopharmaceutical company that discovers, develops, and commercializes therapies for neurological and neuropsychiatric diseases, including rare disorders such as epilepsy, pain and mood disorders, OCD, spinocerebellar ataxia, and spinal muscular atrophy. Its products include Nurtec ODT (rimegepant) for the acute and preventive treatment of migraine.

4 investors

Bioheng develops allogeneic CAR-T cell therapies for cancers and autoimmune diseases, using its Imviva platform and ANSWER technology with immune-evasion science to improve cell therapy performance and persistence. The company operates in the cell therapy and biotechnology field.

1 investor

Bioherent develops label-free biosensors using integrated silicon photonics, surface chemistry, and nanomaterials for in vitro diagnostics, with its AllerWAVE tabletop analyzer and disposable cartridges detecting antibiotic allergies and anaphylaxis for hospitals and labs. It also sells custom silica nanoparticles (NanoKit) for biomedical research and licenses OEM photonic biosensor modules for third-party diagnostic and monitoring platforms.

2 investors